Matches test film-coated tablets clinical trials

Double blind, multicentre, randomized, placebo-controlled trial to evaluate safety and efficacy of pitolisant in children from 6 to less than 18 years with narcolepsy with/without cataplexy, followed by a prolonged open-label period

This study is looking at a medicine called pitolisant for children aged 6 to 17 with narcolepsy. Researchers want to see if it makes their daytime sleepiness and muscle weakness (cataplexy) better and if it's safe to use.